These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 18459994)
1. Overexpression of cyclooxygenase-2 is associated with chemoradiotherapy resistance and prognosis in esophageal squamous cell carcinoma patients. Huang WZ; Fu JH; Wang DK; Hu Y; Liu MZ; Yang H; Feng YF; Zheng B; Wang G; Luo KJ; Wen J; Rong TH Dis Esophagus; 2008; 21(8):679-84. PubMed ID: 18459994 [TBL] [Abstract][Full Text] [Related]
2. Predictive value of COX-2 for the effect of chemoradiotherapy on esophageal squamous cell carcinoma. Takatori H; Natsugoe S; Okumura H; Matsumoto M; Ishigami S; Owaki T; Aikou T Oncol Rep; 2005 Apr; 13(4):697-701. PubMed ID: 15756444 [TBL] [Abstract][Full Text] [Related]
3. COX2 expression predicts resistance to chemoradiotherapy in esophageal squamous cell carcinoma. Akutsu Y; Hanari N; Yusup G; Komatsu-Akimoto A; Ikeda N; Mori M; Yoneyama Y; Endo S; Miyazawa Y; Matsubara H Ann Surg Oncol; 2011 Oct; 18(10):2946-51. PubMed ID: 21437756 [TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2 expression after preoperative chemoradiotherapy correlates with more frequent esophageal cancer recurrence. Yoshikawa R; Fujiwara Y; Koishi K; Kojima S; Matsumoto T; Yanagi H; Yamamura T; Hashimoto-Tamaoki T; Nishigami T; Tsujimura T World J Gastroenterol; 2007 Apr; 13(16):2283-8. PubMed ID: 17511025 [TBL] [Abstract][Full Text] [Related]
5. High cyclooxygenase-2 expression following neoadjuvant radiochemotherapy is associated with minor histopathologic response and poor prognosis in esophageal cancer. Xi H; Baldus SE; Warnecke-Eberz U; Brabender J; Neiss S; Metzger R; Ling FC; Dienes HP; Bollschweiler E; Moenig S; Mueller RP; Hoelscher AH; Schneider PM Clin Cancer Res; 2005 Dec; 11(23):8341-7. PubMed ID: 16322294 [TBL] [Abstract][Full Text] [Related]
6. REG1A expression status suggests chemosensitivity among advanced thoracic esophageal squamous cell carcinoma patients treated with esophagectomy followed by adjuvant chemotherapy. Sato Y; Motoyama S; Nanjo H; Ito S; Yoshino K; Sasaki T; Kuribayashi K; Nagaki Y; Imai K; Saito H; Minamiya Y; Ogawa J Ann Surg Oncol; 2013 Sep; 20(9):3044-51. PubMed ID: 23645481 [TBL] [Abstract][Full Text] [Related]
7. Phosphorylated mammalian target of rapamycin expression is associated with the response to chemoradiotherapy in patients with esophageal squamous cell carcinoma. Li SH; Huang EY; Lu HI; Huang WT; Yen CC; Huang WC; Chen CH J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1352-9, 1359.e1. PubMed ID: 22841170 [TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of vascular endothelial growth factor and cyclooxygenase 2 expression in patients receiving preoperative chemoradiation for esophageal cancer. Kulke MH; Odze RD; Mueller JD; Wang H; Redston M; Bertagnolli MM J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1579-86. PubMed ID: 15173710 [TBL] [Abstract][Full Text] [Related]
9. Comparison between radical esophagectomy and definitive chemoradiotherapy in patients with clinical T1bN0M0 esophageal cancer. Motoori M; Yano M; Ishihara R; Yamamoto S; Kawaguchi Y; Tanaka K; Kishi K; Miyashiro I; Fujiwara Y; Shingai T; Noura S; Ohue M; Ohigashi H; Nakamura S; Ishikawa O Ann Surg Oncol; 2012 Jul; 19(7):2135-41. PubMed ID: 22302264 [TBL] [Abstract][Full Text] [Related]
10. Adjuvant chemotherapy after esophagectomy: is there a role in the treatment of the lymph node positive thoracic esophageal squamous cell carcinoma? Lyu X; Huang J; Mao Y; Liu Y; Feng Q; Shao K; Gao S; Jiang Y; Wang J; He J J Surg Oncol; 2014 Dec; 110(7):864-8. PubMed ID: 24976079 [TBL] [Abstract][Full Text] [Related]
11. Nodal skip metastasis is not a predictor of survival in thoracic esophageal squamous cell carcinoma. Zhu Z; Yu W; Li H; Zhao K; Zhao W; Zhang Y; Sun M; Wei Q; Chen H; Xiang J; Fu X Ann Surg Oncol; 2013 Sep; 20(9):3052-8. PubMed ID: 23686016 [TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic significance of cyclooxygenase-2 overexpression in esophageal squamous cell carcinoma. Kuo KT; Chow KC; Wu YC; Lin CS; Wang HW; Li WY; Wang LS Ann Thorac Surg; 2003 Sep; 76(3):909-14. PubMed ID: 12963227 [TBL] [Abstract][Full Text] [Related]
13. STMN-1 gene: a predictor of survival in stage iia esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy? Akhtar J; Wang Z; Yu C; Zhang ZP; Bi MM Ann Surg Oncol; 2014 Jan; 21(1):315-21. PubMed ID: 23975322 [TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2 expression in squamous cell carcinoma of the esophagus. Liu JF; Jamieson G; Wu TC; Zhang SW; Wang QZ; Drew P Dis Esophagus; 2006; 19(5):350-4. PubMed ID: 16984531 [TBL] [Abstract][Full Text] [Related]
15. Nrf2 is useful for predicting the effect of chemoradiation therapy on esophageal squamous cell carcinoma. Kawasaki Y; Okumura H; Uchikado Y; Kita Y; Sasaki K; Owaki T; Ishigami S; Natsugoe S Ann Surg Oncol; 2014 Jul; 21(7):2347-52. PubMed ID: 24599410 [TBL] [Abstract][Full Text] [Related]
16. PITX2: a promising predictive biomarker of patients' prognosis and chemoradioresistance in esophageal squamous cell carcinoma. Zhang JX; Tong ZT; Yang L; Wang F; Chai HP; Zhang F; Xie MR; Zhang AL; Wu LM; Hong H; Yin L; Wang H; Wang HY; Zhao Y Int J Cancer; 2013 Jun; 132(11):2567-77. PubMed ID: 23132660 [TBL] [Abstract][Full Text] [Related]
17. Comparison between definitive chemoradiotherapy and esophagectomy in patients with clinical stage I esophageal squamous cell carcinoma. Yamamoto S; Ishihara R; Motoori M; Kawaguchi Y; Uedo N; Takeuchi Y; Higashino K; Yano M; Nakamura S; Iishi H Am J Gastroenterol; 2011 Jun; 106(6):1048-54. PubMed ID: 21343920 [TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 expression is related to prognosis in patients with esophageal squamous cell carcinoma. Takatori H; Natsugoe S; Okumura H; Matsumoto M; Uchikado Y; Setoyama T; Sasaki K; Tamotsu K; Owaki T; Ishigami S; Aikou T Eur J Surg Oncol; 2008 Apr; 34(4):397-402. PubMed ID: 17553653 [TBL] [Abstract][Full Text] [Related]
19. Primary mucoepidermoid carcinoma of the esophagus. Chen S; Chen Y; Yang J; Yang W; Weng H; Li H; Liu D J Thorac Oncol; 2011 Aug; 6(8):1426-31. PubMed ID: 21587086 [TBL] [Abstract][Full Text] [Related]
20. Salvage esophagectomy after definitive chemoradiotherapy for thoracic esophageal cancer. Miyata H; Yamasaki M; Takiguchi S; Nakajima K; Fujiwara Y; Nishida T; Mori M; Doki Y J Surg Oncol; 2009 Nov; 100(6):442-6. PubMed ID: 19653262 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]